Doxorubicin-induced cardiomyopathy 17 years after chemotherapy

scientific article

Doxorubicin-induced cardiomyopathy 17 years after chemotherapy is …
instance of (P31):
case reportQ2782326
scholarly articleQ13442814

External links are
P932PMC publication ID3368447
P698PubMed publication ID22719160

P2093author name stringErick Avelar
Ravi Marfatia
Susan Tannenbaum
Simi Kumar
Clifford Yang
P2860cites workMyocarditisQ56933171
Anthracycline-induced cardiotoxicityQ71112913
Doxorubicin cardiomyopathyQ24606920
Late doxorubicin cardiotoxicityQ28317094
Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trialsQ34199968
Acute cardiac toxicity associated with high-dose intravenous methotrexate therapy: case report and review of the literatureQ36257973
Early breast cancer therapy and cardiovascular injury.Q36962419
Early detection and prediction of cardiotoxicity in chemotherapy-treated patientsQ36988282
Anthracycline associated cardiotoxicity in survivors of childhood cancerQ37112428
Cardiovascular complications of cancer therapy: incidence, pathogenesis, diagnosis, and managementQ37516733
Doxorubicin-induced cardiac toxicity and cardiac rest gated blood pool imagingQ37620108
Cardiac toxicity from systemic cancer therapy: a comprehensive review.Q37781587
Doxorubicin cardiac toxicity manifesting seven years after treatment. Case report and reviewQ39729099
Late, late doxorubicin cardiotoxicityQ42273639
P433issue3
P921main subjectcardiomyopathyQ847583
chemotherapyQ974135
P304page(s)424-427
P577publication date2012-01-01
P1433published inTexas Heart Institute JournalQ26841976
P1476titleDoxorubicin-induced cardiomyopathy 17 years after chemotherapy
P478volume39